NGB 2904 (hydrochloride)
目录号 : GC52498A selective D3 antagonist
Cas No.:189061-11-8
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
NGB 2904 is an antagonist that is selective for the dopamine D3 receptor (Ki = 1.4 nM).1 It potently inhibits quinpirole-stimulated mitogenesis (IC50 = 6.8 nM).2 NGB 2904 attenuates cocaine- and stress-induced reinstatement of drug-seeking behavior in rats.3,4 It also increases spontaneous and amphetamine-stimulated locomotion in mice.5
1.Yuan, J., Chen, X., Brodbeck, R., et al.NGB 2904 and NGB 2849: Two highly selective dopamine D3 receptor antagonistsBioorg. Med. Chem. Lett.8(19)2715-2718(1998) 2.Grundt, P., Carlson, E.E., Cao, J., et al.Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptorJ. Med. Chem.48(3)839-848(2005) 3.Gilbert, J.G., Newman, A.H., Gardner, E.L., et al.Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: Role of dopamine D3 receptorsSynapse57(1)17-28(2005) 4.Xi, Z.-X., Newman, A.H., Gilbert, J.G., et al.The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in ratsNeuropsychopharmacology31(7)1393-1405(2006) 5.Pritchard, L.M., Newman, A.H., McNamara, R.K., et al.The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotionPharmacol. Biochem. Behav.86(4)718-726(2007)
Cas No. | 189061-11-8 | SDF | Download SDF |
Canonical SMILES | ClC1=C(Cl)C(N2CCN(CCCCN([H])C(C3=CC(CC4=C5C=CC=C4)=C5C=C3)=O)CC2)=CC=C1.Cl | ||
分子式 | C28H29Cl2N3O ? HCl | 分子量 | 530.9 |
溶解度 | DMSO: 25 mM,Ethanol: 5 mM | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.8836 mL | 9.418 mL | 18.8359 mL |
5 mM | 0.3767 mL | 1.8836 mL | 3.7672 mL |
10 mM | 0.1884 mL | 0.9418 mL | 1.8836 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。